GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Long-Term Debt

Genflow Biosciences (STU:WQ5) Long-Term Debt : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Long-Term Debt?

Genflow Biosciences's Long-Term Debt for the quarter that ended in Jun. 2024 was €0.00 Mil.


Genflow Biosciences Long-Term Debt Historical Data

The historical data trend for Genflow Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Long-Term Debt Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Long-Term Debt
- - -

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Long-Term Debt Get a 7-Day Free Trial - - - - -

Genflow Biosciences  (STU:WQ5) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Genflow Biosciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines